CClinicalTrials.gg
Status unknownNCT04995458CerasmartUpdated Jan 25, 2023

Clinical Evaluation of Composite-ceramic Implant-supported Posterior Crowns (Cerasmart)

An interventional study of composite-ceramic and Monolithic zirconia in Dental Materials, sponsored by Universidad Complutense de Madrid. Status unknown at 1 site in Spain. Open to participants aged 25 Years to 75 Years. Per ClinicalTrials.gov, last updated 2023-01-25.

Sponsored by Universidad Complutense de Madrid · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 4 years 1 month after the study started (first participant enrolled Jun 2017, registered Aug 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
25 Years to 75 Years
Sex
All
01

Study summary

The objectives of the present study are to analyze and to compare the survival rates and possible biological and technical complications arising from the use of composite-ceramic posterior implant-supported crowns with those obtained when using their counterparts prepared using monolithic zirconia restorations. The null hypothesis is that no differences would be found between the parameters studied for each type of restoration.

Read the detailed description

Eighty patients in need of posterior implant-supported crowns (n=80) were recruited from the Master of Buccofacial Prostheses and Occlusion, Faculty of Odontology, University Complutense of Madrid, Madrid, Spain. Before treatment, all participants were informed of the purpose of the study, the clinical procedures, the material to be used, and the advantages and risks of the restorations. They were asked to give their written informed consent to participate in the study.

Eighty posterior implant-supported crowns were produced and allocated in parallel an randomly to either monolithic zirconia or composite-ceramic restorations by means of a randomization list. A total of 40 implant-supported crowns were placed using monolithic zirconia and 40 composite-ceramic. The clinical procedures were performed by two experienced clinicians. Full-arch impressions were taken using addition silicone. The restorations were cemented using a resin-based cement. The occlusion was adjusted and the surfaces polished after cementing. All restorations were prepared by an experienced technician. The restorations will be examined at one week (baseline), 1, 2, and 3 years by two researchers who were not involved in the restorative treatment. Each assessor evaluated the restoration independently, and the worst assessment will be used in the event of discrepancies.

02

Conditions studied

  • Dental Materials

Keywords

  • implant-supported crowns
  • monolithic zirconia
  • composite-ceramic
  • clinical evaluation
  • survival
03

In context

Lead sponsor

Universidad Complutense de Madrid is the lead sponsor of 200 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • One posterior tooth (molar or premolar) to restore, and with opposing tooth

Exclusion criteria

Exclusion Criteria:

  • unacceptable oral hygiene
  • bruxism
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Composite-ceramic

    To assess the clinical performance and survival of posterior composite-ceramic implant-supported crowns

    Procedure: composite-ceramic

  • Active comparator
    Monolithic zirconia

    To assess the clinical performance and survival of posterior monolitihic zirconia implant-supported crowns

    Procedure: Monolithic zirconia

Interventions

  • Procedurecomposite-ceramic

    To assess the clinical performance of composite-ceramic crowns

    Also known as: Cerasmart

  • ProcedureMonolithic zirconia

    To assess the clinical performance of monolithic z¡irconia crowns

06

What researchers measure

Primary outcomes

  1. Quality of restorations at baseline

    The quality of the surface and color, anatomical form and marginal integrity was assessed using the California Dental Association's (CDA) assessment system. Each CDA criterion was ranked on a scale of 1 to 4, where 4 = excellent, 3 = good, 2 = unacceptable (repair), and 1 = unacceptable (replacement).

    Time frame: Baseline

  2. Quality of restorations at 1 year

    The quality of the surface and color, anatomical form and marginal integrity was assessed using the California Dental Association's (CDA) assessment system. Each CDA criterion was ranked on a scale of 1 to 4, where 4 = excellent, 3 = good, 2 = unacceptable (repair), and 1 = unacceptable (replacement).

    Time frame: 1 year

  3. Quality of restorations at 2 year

    The quality of the surface and color, anatomical form and marginal integrity was assessed using the California Dental Association's (CDA) assessment system. Each CDA criterion was ranked on a scale of 1 to 4, where 4 = excellent, 3 = good, 2 = unacceptable (repair), and 1 = unacceptable (replacement).

    Time frame: 2 years

  4. Quality of restorations at 3 year

    The quality of the surface and color, anatomical form and marginal integrity was assessed using the California Dental Association's (CDA) assessment system. Each CDA criterion was ranked on a scale of 1 to 4, where 4 = excellent, 3 = good, 2 = unacceptable (repair), and 1 = unacceptable (replacement).

    Time frame: 3 years

  5. Plaque Index (PI) at baseline

    Plaque Index (PI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Time frame: baseline

  6. Plaque Index (PI) at 1 year

    Plaque Index (PI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Time frame: 1 year

  7. Plaque Index (PI) at 2 years

    Plaque Index (PI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Time frame: 2 years

  8. Plaque Index (PI) at 3 years

    Plaque Index (PI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Time frame: 3 years

  9. Gingival Index (GI) at baseline

    Gingival Index (GI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Time frame: Baseline

  10. Gingival Index (GI) at 1 year

    Gingival Index (GI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Time frame: 1 year

  11. Gingival Index (GI) at 2 years

    Gingival Index (GI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Time frame: 2 years

  12. Gingival Index (GI) at 3 years

    Gingival Index (GI) of the abutment and control teeth. A score of 0 to 3 was assigned. Higher score means a worse outcome.

    Time frame: 3 years

  13. Probing depth at baseline

    Probing depth of the abutment. A score of 0 to 4 was assigned. Higher score means a worse outcome

    Time frame: Baseline

  14. Probing depth at 1 year

    Probing depth of the abutment. A score of 0 to 4 was assigned. Higher score means a worse outcome

    Time frame: 1 year

  15. Probing depth at 2 year

    Probing depth of the abutment. A score of 0 to 4 was assigned. Higher score means a worse outcome

    Time frame: 2 years

  16. Probing depth at 3 year

    Probing depth of the abutment teeth. A score of 0 to 4 was assigned. Higher score means a worse outcome

    Time frame: 3 years

07

Study locations

1 site
  • Faculty of Odontology
    Madrid, 28040, Spain
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04995458
Lead sponsor
Universidad Complutense de Madrid
Collaborators
GC Europe
Responsible party
Sponsor
First posted
Aug 9, 2021
Start date
Jun 5, 2017
Primary completion
Jul 20, 2019
Completion
Jun 20, 2023 (estimated)
Last update
Jan 25, 2023

Study contacts

MARIA J SUAREZ, PhD
study director · Universidad Complutense de Madrid

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion